Yuhan
🇰🇷South Korea
- Country
- 🇰🇷South Korea
- Ownership
- -
- Established
- 1926-01-01
- Employees
- -
- Market Cap
- $7.4B
- Website
- http://www.yuhan.co.kr
As of 1:30 p.m. on the 26th, the top 1% of stock investment returns were confirmed to have net purch..
Top 1% investors net purchased Yuhan, Alteogen, and HD Hyundai Heavy Industries as of 1:30 p.m. on the 26th, while net selling Doosan, Korea Electric Power Corp., and Daedong. Yuhan's stock price fell 3.89%, seen as a buying opportunity, and Alteogen's stock price dropped 33%, also attracting buyers.
[INTERVIEW] ABL Bio has grown from go-getter to go-to company
ABL Bio's CEO highlights the company's growth since a $1.06B deal with Sanofi for ABL301, a Parkinson's treatment. ABL Bio now attracts global interest, plans clinical trials for ABL301, ABL101, ABL103, and seeks more licensing deals. The CEO emphasizes the importance of strategic growth and maturity in Korea's biopharmaceutical industry.
© Copyright 2025. All Rights Reserved by MedPath